IGF1R and cancer: Crosstalk between EGFR and other RTKs, such as ErbB-family members [16], c-Met [15] and Insulin-like growth factor 1 receptor (IGF-1R) [17, 18], are vital in ascertaining the mechanisms of drug resistance in cancer treatment.